Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Adamas Pharma (NQ: ADMS )

5.163 USD +0.133 (+2.65%)
Streaming Delayed Price Updated: 3:03 PM EST, Mar 2, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Adamas Pharma

< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
Adamas Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced... 
From Business Wire News Releases
The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags SRPT ICLR BMRN
From Benzinga
Adamas Pharmaceuticals Announces Pricing of Follow-on Public Offering
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced... 
From Business Wire News Releases
Adamas Pharmaceuticals Announces Launch of Follow-on Public Offering
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced... 
From Business Wire News Releases
First Week of April 16th Options Trading For Adamas Pharmaceuticals (ADMS)
Investors in Adamas Pharmaceuticals Inc (ADMS) saw new options begin trading this week, for the April 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ADMS... 
Tags Stocks
From Market News Video
Adamas Pharmaceuticals: Q4 Earnings Insights
Shares of Adamas Pharmaceuticals (NASDAQ:ADMS) rose in after-market trading after the company reported Q4 results. Quarterly ... 
Tags Market News Earnings Benzinga
From Benzinga
Adamas Reports Fourth Quarter and Full Year 2020 Financial Results
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today reported... 
From Business Wire News Releases
The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags INSP ARDS MDT
From Benzinga
Earnings Scheduled For February 23, 2021
Companies Reporting Before The Bell • MFA Finl (NYSE:MFA) is likely to report quarterly earnings at $0.07 per share on ... 
Tags ALC FLS AXDX
From Benzinga
A Preview Of Adamas Pharmaceuticals's Earnings
Adamas Pharmaceuticals (NASDAQ:ADMS) announces its next round of earnings this Tuesday, February 23. Here is Benzinga's ... 
Tags Market News Earnings BZI/EP
From Benzinga
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
Biotech stocks pulled back along with the broader market in the holiday-shortened week ended Feb 19. Earnings news flow was light before ... 
Tags MDT CNCE NKTR
From Benzinga
Adamas to Present at Upcoming Healthcare Conferences
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced... 
From Business Wire News Releases
Adamas to Announce Fourth Quarter and Year-End 2020 Financial Results and Host Conference Call on February 23, 2021
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the company will report fourth quarter and year-end 2020 financial results on Tuesday, February 23, 2021, after market close.... 
From Business Wire News Releases
90 Biggest Movers From Yesterday
Gainers Cassava Sciences, Inc.. (NASDAQ: SAVA) shares jumped 141.2% to close at $55.44 on Tuesday after the company announced ... 
Tags JRJC SIEB EXK
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Cassava Sciences (NASDAQ:SAVA) stock moved upwards by 123.66% to $51.42 during Tuesday's regular session. As ... 
Tags AEZS Top Gainers IMVT
From Benzinga
60 Stocks Moving In Tuesday's Mid-Day Session
Gainers Lizhi Inc. (NASDAQ: LIZI) shares climbed 64.6% to $6.01. American Resources Corporation (NASDAQ: AREC) gained 56% to ... 
Tags ADMS ATOS MUX
From Benzinga
The Daily Biotech Pulse: Vertex, Pfizer Earnings, Tiziana COVID-19 Vaccine Data, Decision Day For Mallinckrodt's Burn Treatment
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags IBB VRTX NLSP
From Benzinga
38 Stocks Moving in Tuesday's Pre-Market Session
Gainers Artelo Biosciences, Inc. (NASDAQ: ARTL) shares rose 126.9% to $2.36 in pre-market trading after climbing over 8% on ... 
Tags BFIN BDR CRBP
From Benzinga
102 Biggest Movers From Yesterday
Gainers Leisure Acquisition Corp. (NASDAQ: LACQ) shares jumped 111.2% to close at $23.99 on Monday after the company entered into ... 
Tags News SFIX YGMZ
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Corbus Pharmaceuticals (NASDAQ:CRBP) shares moved upwards by 16.59% to $2.6 during Monday's after-market session. This ... 
Tags ARQT ADMA Benzinga
From Benzinga
Adamas Announces FDA Approval for Second Indication for GOCOVRI® as an Adjunctive Treatment to levodopa/carbidopa in Parkinson’s Disease Patients Experiencing OFF Episodes
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced it... 
From Business Wire News Releases
70 Stocks Moving In Monday's Mid-Day Session
Gainers Viela Bio, Inc. (NASDAQ: VIE) shares surged 52.6% to $52.91 after the company agreed to be acquired by Horizon ... 
Tags VBIV AIRT YQ
From Benzinga
Adamas Announces Settlement of Patent Litigation with Zydus
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a clinically meaningful difference to people affected by neurological diseases, today... 
From Business Wire News Releases
Attention Biotech Investors: Mark Your Calendar For February PDUFA Dates
Coming off a stellar year, when a record 53 new molecular entities were approved, 2021 has a lot to live up to. NMEs are a measure of ... 
Tags GTHX TGTX Market News
From Benzinga
The Week Ahead In Biotech: Merck, Pfizer In Earnings Mix, Plus Adamas, Mallinckrodt FDA Decisions, IPOs, And More
Biotech stocks alternated between gains and losses in the week ended Jan. 29 before ending lower. Big pharma earnings season kick started, with Novartis AG, Johnson & Johnson, and Eli Lilly And Co all... 
Tags Stocks / Equities Healthcare Pharma/Biotech
From Blogs - TalkMarkets
The Week Ahead In Biotech: Merck, Pfizer In Earnings Mix, Plus Adamas, Mallinckrodt FDA Decisions, IPOs And More
Biotech stocks alternated between gains and losses in the week ended Jan. 29 before ending lower. Big pharma earnings season kick ... 
Tags VIVO NBIX Penny Stocks
From Benzinga
100 Biggest Movers From Yesterday
Gainers EZGO Technologies Ltd(NASDAQ: EZGO) shares jumped around 352.8% to close at $18.11on Tuesday after the company ... 
Tags BZUN NKLA ECOR
From Benzinga
55 Stocks Moving In Tuesday's Mid-Day Session
Gainers Oxbridge Re Holdings Limited (NASDAQ: OXBR) gained 65% to $3.96. Vertex Energy, Inc. (NASDAQ: VTNR) shares surged 62.6% ... 
Tags EXPR KOSS USWS
From Benzinga
38 Stocks Moving in Tuesday's Pre-Market Session
Gainers Koss Corporation (NASDAQ: KOSS) shares rose 69% to $10.17 in pre-market trading. Koss gained around 80% on Monday as the ... 
Tags LAIX ATOS Health Care
From Benzinga
Adamas Provides Preliminary Fourth Quarter and Full Year 2020 Total Revenues and Key Business Drivers for 2021
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.